202 related articles for article (PubMed ID: 38566223)
41. Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma.
Li Z; Zhang X; Xue W; Zhang Y; Li C; Song Y; Mei M; Lu L; Wang Y; Zhou Z; Jin M; Bian Y; Zhang L; Wang X; Li L; Li X; Fu X; Sun Z; Wu J; Nan F; Chang Y; Yan J; Yu H; Feng X; Wang G; Zhang D; Fu X; Zhang Y; Young KH; Li W; Zhang M
Nat Commun; 2019 Sep; 10(1):4209. PubMed ID: 31527657
[TBL] [Abstract][Full Text] [Related]
42. TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression.
Huang HS; Liao CK; Liu TT; You HL; Wang MC; Huang WT
Hum Pathol; 2018 Oct; 80():145-151. PubMed ID: 29885407
[TBL] [Abstract][Full Text] [Related]
43. Liquid biopsy in extranodal NK/T-cell lymphoma: a prospective analysis of cell-free DNA genotyping and monitoring.
Qi F; Cao Z; Chen B; Chai Y; Lin J; Ye J; Wei Y; Liu H; Han-Zhang H; Mao X; Feng X; Dong M
Blood Adv; 2021 Jun; 5(11):2505-2514. PubMed ID: 34047776
[TBL] [Abstract][Full Text] [Related]
44. Prognostic implications of CD30 expression in extranodal natural killer/T-cell lymphoma according to treatment modalities.
Kim WY; Nam SJ; Kim S; Kim TM; Heo DS; Kim CW; Jeon YK
Leuk Lymphoma; 2015 Jun; 56(6):1778-86. PubMed ID: 25288491
[TBL] [Abstract][Full Text] [Related]
45. Characteristics, Prognostic Factors, and Survival of Patients with NK/T-Cell Lymphoma of Non-upper Aerodigestive Tract: A 17-Year Single-Center Experience.
Liu ZL; Bi XW; Zhang XW; Lei DX; Liu PP; Yang H; Gao Y; Jiang YX; Jiang WQ; Xia Y
Cancer Res Treat; 2019 Oct; 51(4):1557-1567. PubMed ID: 30971067
[TBL] [Abstract][Full Text] [Related]
46. Elevated serum IL-6 and total IgEAb are associated with poor survival in natural killer/T-cell lymphoma.
Hui Y; Gao Y; Li J; Kong Q; Duan Y; Liu H; Liu F; Sang H
Ann Hematol; 2024 Apr; 103(4):1285-1292. PubMed ID: 38095656
[TBL] [Abstract][Full Text] [Related]
47. Brentuxinmab vedotin, alone or combine with bendamustine in the treatment of natural killer T cell lymphoma.
Zhang P; Shi C; Song Y; Li Z; Zhang M; Jin M
Hematol Oncol; 2022 Dec; 40(5):941-952. PubMed ID: 35797410
[TBL] [Abstract][Full Text] [Related]
48. c-Myc mediated upregulation of long noncoding RNA SNHG12 regulates proliferation and drug sensitivity in natural killer/T-cell lymphoma.
Zhu L; Zhang X; Fu X; Li Z; Sun Z; Wu J; Wang X; Wang F; Li X; Niu S; Ding M; Yang Z; Yang W; Yin M; Zhang L; Zhang M
J Cell Biochem; 2019 Aug; 120(8):12628-12637. PubMed ID: 30825244
[TBL] [Abstract][Full Text] [Related]
49. Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma.
Liu Z; Sarathkumara YD; Chan JKC; Kwong YL; Lam TH; Ip DKM; Chiu BC; Xu J; Su YC; Proietti C; Cooper MM; Yu KJ; Bassig B; Liang R; Hu W; Ji BT; Coghill AE; Pfeiffer RM; Hildesheim A; Rothman N; Doolan DL; Lan Q
Sci Rep; 2021 Dec; 11(1):23664. PubMed ID: 34880297
[TBL] [Abstract][Full Text] [Related]
50. IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma.
Wang L; Bi XW; Zhu YJ; He YZ; Lai QY; Xia ZJ; Cai QQ
Cancer Commun (Lond); 2018 Oct; 38(1):62. PubMed ID: 30340635
[TBL] [Abstract][Full Text] [Related]
51. Analysis of mutation profiles in extranodal NK/T-cell lymphoma: clinical and prognostic correlations.
Chang YC; Tsai HJ; Huang TY; Su NW; Su YW; Chang YF; Chen CG; Lin J; Chang MC; Chen SJ; Chen HC; Lim KH; Chang KC; Kuo SH
Ann Hematol; 2024 Apr; ():. PubMed ID: 38671297
[TBL] [Abstract][Full Text] [Related]
52. The exact Deauville score, NABS score and high SUVmax predicts outcome in extranodal natural killer/T-cell lymphoma.
Huang HL; Ngam PI; Tan KM; Ng DCE; Lim ST; Chan JY
Ann Nucl Med; 2021 May; 35(5):557-568. PubMed ID: 33683545
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of sonic hedgehog signaling blocks cell migration and growth but induces apoptosis via suppression of FOXQ1 in natural killer/T-cell lymphoma.
Liu P; Chen L
Leuk Res; 2018 Jan; 64():1-9. PubMed ID: 29132010
[TBL] [Abstract][Full Text] [Related]
54. Identification of microRNAs modulated by DNA hypomethylating drugs in extranodal NK/T-cell lymphoma.
Go H; Jang JY; Kim CW; Huh J; Kim PJ; Jeon YK
Leuk Lymphoma; 2020 Jan; 61(1):66-74. PubMed ID: 31441360
[TBL] [Abstract][Full Text] [Related]
55. Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma.
Li X; Cheng Y; Zhang M; Yan J; Li L; Fu X; Zhang X; Chang Y; Sun Z; Yu H; Zhang L; Wang X; Wu J; Li Z; Nan F; Tian L; Li W; Young KH
J Hematol Oncol; 2018 Jan; 11(1):15. PubMed ID: 29386072
[TBL] [Abstract][Full Text] [Related]
56. Selinexor With Anti-PD-1 Antibody as a Potentially Effective Regimen for Patients With Natural Killer/T-Cell Lymphoma Failing Prior L-Asparaginase and PD-1 Blockade.
Tao R; Liu C; Zhang W; Zhu Y; Ma Y; Hao S
Oncologist; 2024 Jan; 29(1):e90-e96. PubMed ID: 37616529
[TBL] [Abstract][Full Text] [Related]
57. L-asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type.
Yong W; Zheng W; Zhu J; Zhang Y; Wang X; Xie Y; Lin N; Xu B; Lu A; Li J
Ann Hematol; 2009 Jul; 88(7):647-52. PubMed ID: 19107482
[TBL] [Abstract][Full Text] [Related]
58. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
Vose J; Armitage J; Weisenburger D;
J Clin Oncol; 2008 Sep; 26(25):4124-30. PubMed ID: 18626005
[TBL] [Abstract][Full Text] [Related]
59. Comparative analysis of upper aerodigestive tract and non-upper aerodigestive tract in NK/T-cell lymphoma.
Liu X; Cao D; Liu H; Ke X; Liu X; Xu X
Clin Transl Oncol; 2024 Jan; 26(1):214-224. PubMed ID: 37351807
[TBL] [Abstract][Full Text] [Related]
60. Suppression of latent transforming growth factor-β (TGF-β)-binding protein 1 (LTBP1) inhibits natural killer/ T cell lymphoma progression by inactivating the TGF-β/Smad and p38
Lin R; Li X; Wu S; Qian S; Hou H; Dong M; Zhang X; Zhang M
Exp Cell Res; 2021 Oct; 407(1):112790. PubMed ID: 34418460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
